Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Environ Toxicol. 2012 Apr 4;29(4):466–477. doi: 10.1002/tox.21773

Fig. 5.

Fig. 5

PMPMEase activity in Galaxolide- and Tonalide-treated human lung cancer A549 cells. A549 cells were cultured and seeded in 24-well plates (106 cells/mL) containing serum-free RPMI 1640/F12 medium as described in the methods. Cells were treated with varying concentrations of Galaxolide and Tonalide (1–200 µM) for 24 h. They were then lysed for the determination of PMPMEase activity using RDPNB as the substrate. The results are relative to the controls and are the means (±SEM, N = 4).